113P Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on durvalumab eligibility and safety profile
Title:
113P Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on durvalumab eligibility and safety profile
Author:
Cortiula, F. De Ruysscher, D. Dursun, S. Steens, M. Bootsma, G. Canters, R. Rinaldi, I. Taasti, V.T. Houben, R. Reynders, K. Peeters, S. Angrisani, A. Hattu, D. Hendriks, L.